MoonLake Immunotherapeutics (MLTX)
17.77
+0.28
(+1.60%)
USD |
NASDAQ |
Jun 11, 13:36
MoonLake Immunotherapeutics Market Cap : 1.282B for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 1.262B |
| June 09, 2026 | 1.284B |
| June 08, 2026 | 1.298B |
| June 05, 2026 | 1.291B |
| June 04, 2026 | 1.350B |
| June 03, 2026 | 1.318B |
| June 02, 2026 | 1.289B |
| June 01, 2026 | 1.358B |
| May 29, 2026 | 1.384B |
| May 28, 2026 | 1.347B |
| May 27, 2026 | 1.355B |
| May 26, 2026 | 1.342B |
| May 22, 2026 | 1.339B |
| May 21, 2026 | 1.360B |
| May 20, 2026 | 1.255B |
| May 19, 2026 | 1.205B |
| May 18, 2026 | 1.210B |
| May 15, 2026 | 1.292B |
| May 14, 2026 | 1.354B |
| May 13, 2026 | 1.355B |
| May 12, 2026 | 1.339B |
| May 11, 2026 | 1.387B |
| May 08, 2026 | 1.256B |
| May 07, 2026 | 1.266B |
| May 06, 2026 | 1.303B |
| Date | Value |
|---|---|
| May 05, 2026 | 1.220B |
| May 04, 2026 | 1.260B |
| May 01, 2026 | 1.200B |
| April 30, 2026 | 1.175B |
| April 29, 2026 | 1.156B |
| April 28, 2026 | 1.195B |
| April 27, 2026 | 1.209B |
| April 24, 2026 | 1.232B |
| April 23, 2026 | 1.214B |
| April 22, 2026 | 1.235B |
| April 21, 2026 | 1.235B |
| April 20, 2026 | 1.283B |
| April 17, 2026 | 1.315B |
| April 16, 2026 | 1.276B |
| April 15, 2026 | 1.293B |
| April 14, 2026 | 1.347B |
| April 13, 2026 | 1.322B |
| April 10, 2026 | 1.288B |
| April 09, 2026 | 1.392B |
| April 08, 2026 | 1.334B |
| April 07, 2026 | 1.225B |
| April 06, 2026 | 1.218B |
| April 02, 2026 | 1.245B |
| April 01, 2026 | 1.185B |
| March 31, 2026 | 1.337B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BeOne Medicines Ltd. | 26.77B |
| AC Immune SA | 224.85M |
| CRISPR Therapeutics AG | 4.871B |
| Idorsia Ltd. | 1.442B |
| ADC Therapeutics SA | 139.88M |
Market Cap Related Metrics
| PEG Ratio | -0.0674 |
| Price to Book Value | 5.046 |
| Price | 17.77 |
| Earnings Yield | -21.79% |
| PEGY Ratio | -0.0674 |